|
| Status |
Public on Aug 27, 2014 |
| Title |
Testing gene expression changes in VCaP upon depletion of the mutated ETS transcription factor ERG |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
VCaP cells expressing inducible shRNAs for either ERG or a non-targeting control were treated with Doxycycline for 1, 3, 7 and 10 days prior to collection
This experiment is designed to see which genes and pathways are modulated by ERG knockdown
|
| |
|
| Overall design |
VCaP cells stably expressing a Doxycycline (dox)-inducible control nontargeting shRNA (Pak4) or an ERG shRNA (2217) were exposed to 100ng/ml Dox for the noted days.
|
| |
|
| Contributor(s) |
Mounir Z, Pagliarini R, Rocnik J, Bellavance K, Korn JM |
| Citation(s) |
25263440 |
| |
| Submission date |
Aug 26, 2014 |
| Last update date |
Mar 25, 2019 |
| Contact name |
Joshua M Korn |
| E-mail(s) |
joshkorn@gmail.com
|
| Organization name |
Novartis
|
| Street address |
250 Mass Ave
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02141 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
| Samples (16)
|
|
| Relations |
| BioProject |
PRJNA259524 |
Less...
More...